Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GBT targets AI-controlled communications markets which are constantly expanding, and to address this expansion, GBT is designing a new architecture of RNN that is based on a proprietary LSTR (Long/Short Term Memory) algorithm.$GTCH
GBT Technologies Inc., is focused on developing mobile microchip (ICs) and software technologies based on the GopherInsight technology platform. $GTCH
GBT is designing a new architecture of RNN that is based on a proprietary LSTR (Long/Short Term Memory) algorithm. The new RNN will seek to offer robust training capabilities along with vast computational power. The new RNN is designed to store and distribute vast amounts of information about past and present events efficiently.$GTCH
GBT is currently evaluating advanced optical electronic systems. An integrated optical solution consumes low power and provides high accuracy.$GTCH
GBT's 3D microchip patent is protecting GBT's futuristic integrated circuit technology which introduces new systems and methods for microchip's manufacturing. The invention is designed to present a new die structure and orientation with a focus on deep nanometer range.$GTCH
GBT decided to enhance its Epsilon reliability software package, preparing for advanced nodes like 5nm and the upcoming 3nm. This is a major decision since 7nm and 5nm are still a traditional FinFet approach, but with the upcoming 3nm is another device architecture.$GTCH
GBT intends to explore various practical uses for technology including with memory cells, micro solar cells and MEMS chips enabling larger silicon areas that will create new horizons for the creation of advanced, miniaturized electro-mechanical systems like micro-sensors and micro-actuators with the goal of creating advanced AI, CPU and powerful GPUs within smaller areas.$GTCH
GBT's invention goes beyond 3D concept with multi-plane silicon structures, for example honeycomb, hexagonal and further multi-planetary structures, in order to significantly increase silicon surface area. These types of structures are designed to enable the design and manufacture chips with multi-trillion transistors on die, creating new horizons for mega-chips with mega features.$GTCH
GBT's 3D microchip patent is protecting GBT's futuristic integrated circuit technology which introduces new systems and methods for microchip's manufacturing. The invention is designed to present a new die structure and orientation with a focus on deep nanometer range.$GTCH
GBT envisions a low-cost, secure, private mesh network between any enabled devices, providing shared processing, advanced mobile database management/sharing and enhanced mobile features as an alternative to traditional carrier services.$GTCH
GBT has a portfolio of Intellectual Property that, if commercialized, is designed to include smart microchips, mobile and security applications and protocols and supporting cloud software. GBT’s system envisions the creation of a global mesh network.$GTCH
With Alpha EDA, LLC GBT developed a set of algorithms and solutions that they believe will address advanced nodes.$GTCH
Good Afternoon
Using Kirlian imaging, GBT believes it is possible to produce a measure of human energy levels and examine changes in the energy distribution throughout the organ(s). We are attempting to determine if we can implement Kirlian imaging for qTerm by means of producing a human's finger aura (i.e. its biofield).$GTCH
GBT/Tokenize's Machine Learning system is aimed to analyze the biofield data and possible detection of onset disease. Based on Kirlian images and patterns, GBT/Tokenize's AI seeks to observe, study, analyze and ultimately alert physicians about possible underlying illnesses or symptoms.$GTCH
GBT Technologies Inc. 's (OTC Pink: GTCH) AI-powered qTerm human vital signs device is adding a blood pressure measurement feature.This feature was intended to be included in the first version of the qTerm device but was delayed in an effort to get the device to market sooner to help with the COVID-19 pandemic.$GTCH
GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”), announced as continuance update to its press release from October 5, 2020, that its mobile database sharing, non-provisional patent received its final grant status and will be officially published on December 1, 2020.$GTCH
GBT envisions a low-cost, secure, private mesh network between any enabled devices, providing shared processing, advanced mobile database management/sharing and enhanced mobile features as an alternative to traditional carrier services.$GTCH
GBT/Tokenize’s blood pressure solution will comprise a complete integrated optical sensor module, and an embedded microcontroller.$GTCH
GBT/Tokenize has decided to introduce an initial release of qTerm. The early release of the product will include body temperature, heart rate and blood oxygen level features and is targeted to be released by the end of this year.$GTCH
GBT is currently evaluating advanced optical electronic systems. An integrated optical solution consumes low power and provides high accuracy.$GTCH
GBT/Tokenize’s blood pressure solution will comprise a complete integrated optical sensor module, and an embedded microcontroller. A sensing firmware algorithm will provide the operation and control of the entire system. Such method is called photoplethysmography (PPG) and its goal is to detect blood volume changes in the microvascular tissues.$GTCH
GBT/Tokenize is now checking the best radio frequencies to be used starting at 0.1hz up to 20Mhz range. The new circuit is planned to sweep frequencies within a designated range, in order to enhance data security and signal reliability.$GTCH
GBT together with Alpha EDA (“Alpha”), its joint venture partner, have developed IC design productivity enhancement algorithms and methods.$GTCH
GBT's database management system is targeted to be governed by our Avant! AI engine to ensure integrity, reliability and security.$GTCH
GBT's 3D microchip patent is protecting GBT's futuristic integrated circuit technology which introduces new systems and methods for microchip's manufacturing.$GTCH
GBT has a portfolio of Intellectual Property that, if commercialized, is designed to include smart microchips, mobile and security applications and protocols and supporting cloud software. GBT’s system envisions the creation of a global mesh network.$GTCH
GBT's 3D microchip patent is protecting GBT's futuristic integrated circuit technology which introduces new systems and methods for microchip's manufacturing.$GTCH
GBT/Tokenize is now checking the best radio frequencies to be used starting at 0.1hz up to 20Mhz range. The new circuit is planned to sweep frequencies within a designated range, in order to enhance data security and signal reliability. In addition, the signals are planned to be encrypted and working in 2-way handshake protocol.$GTCH
The new radio system is aimed to enable qTerm as a private, secured, MESH radio communication network. GBT/Tokenize has developed the technology for a radio based network that can be used for IoT and mobile devices. A successful MESH network system was tested in 2019.$GTCH
GBT Tokenize (“GBT/Tokenize”) commenced a new radio system development for its qTerm device.$GTCH
GBT/Tokenize's Machine Learning system is aimed to analyze the biofield data and possible detection of onset disease. Based on Kirlian images and patterns, GBT/Tokenize's AI seeks to observe, study, analyze and ultimately alert physicians about possible underlying illnesses or symptoms.$GTCH
GBT/Tokenize encourages public participation in its research. Scientists and researchers that are interested to participate in our research are welcome to send us their material for evaluation at kirlian_research@qterm.me$GTCH
GBT Tokenize Commencing Open Public Research in Kirlian Electrophotography Technique. $GTCH
GBT Technologies Inc. 's (OTC Pink: GTCH) AI-powered qTerm human vital signs device is adding a blood pressure measurement feature, according to a recent press release.$GTCH
GBT plans to continue expanding the features and AI capabilities of the device on subsequent versions as well. In fact, it was recently announced that the company's joint venture, GBT Tokenize, had begun developing a new radio system for the device.$GTCH
Immune Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.$IMUN
GBT Technologies Inc. 's (OTC Pink: GTCH) AI-powered qTerm human vital signs device is adding a blood pressure measurement feature.$GTCH
GBT is a California-based company that is introducing what can only be seen as a disruptive technology in an industry that is red hot and seemingly growing exponentially year-over-year.$GTCH
GBT Technologies (GBT)is ideally positioned to compete in what Gartner, a leading research and advisory firm, estimates will be an almost $4-trillion market by 2022.$GTCH